Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 80185 in adolescent scalp psoriasis
NCT01083758Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Apr 2010
- Primary completion
- Aug 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of AKP01, betamethasone dipropionate spray 0.05% in psoriasis, sponsored by LEO Pharma. Started Apr 2010; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01083758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01083758.